Senescence-directed nanotherapy ameliorates fibrosis and overcomes immune exclusion in cancer
Hinterleitner, C.; Barthet, V. J. A.; Goldberg, H. V.; Vogt, K. C.; Perea, A. M.; Ruiz, S.; Hillger, L. R.; McHugh, D.; Ho, Y.-J.; Chaves-Perez, A.; Skamagki, M.; Flowers, S.; Rekhtman, N.; Zhuang, X.; Barretto, G. D.; Li, X.; Watson, J. T.; Luan, W.; Simon, J.; Tammela, T.; Gardner, R.; Rudin, C. M.; Romesser, P. B.; Bott, M. J.; Filliol, A.; Heller, D. A.; Lowe, S. W.
Show abstract
Fibrotic remodeling of tissues and tumors establishes immune-suppressive microenvironments that drive organ dysfunction and, in cancer, limit responses to immunotherapy. Cells exhibiting features of cellular senescence are conserved drivers of fibrotic remodeling and thus represent therapeutic targets, yet senescent states are heterogeneous and can exert both beneficial and pathogenic effects, complicating therapeutic intervention. Here, we show that P-selectin is selectively expressed by subsets of senescent-like cells in fibrotic tissues and fibrotic tumor microenvironments. Leveraging fucoidan-based nanoparticles that bind P-selectin, we develop senescence-modulating nanoparticles (SMNPs) to selectively target these disease-associated cell states. SMNPs exhibit potent antifibrotic and immunomodulatory activity while markedly improving therapeutic index. Mechanistically, we identify a pathogenic, immune-suppressive macrophage population as a principal functional target of SMNPs in vivo. In fibrotic tumors, niche remodeling restores immune infiltration and sensitizes tumors to immune checkpoint-based therapies. More broadly, SMNPs establish a generalizable nanotherapeutic strategy for selectively targeting pathogenic senescent cell subsets across fibrotic disease and cancer.
Matching journals
The top 8 journals account for 50% of the predicted probability mass.
Similar papers in this journal
- An organoid co-culture model for probing systemic anti-tumor immunity in lung cancer 95%
- Autophagy counters inflammation-driven glycolytic impairment in aging hematopoietic stem cells 93%
- Niche-driven phenotypic plasticity and cis-regulatory dynamics of a revised model for intestinal secretory differentiation 93%
Similar papers in this journal
- Desmoplastic stroma restricts T cell extravasation and mediates immune exclusion and immunosuppression in solid tumors 95%
- Cancer cell genetics shaping of the tumor microenvironment reveals myeloid cell-centric exploitable vulnerabilities in hepatocellular carcinoma 94%
- In vivo CRISPR screens reveal Serpinb9 and Adam2 as regulators of immune therapy response in lung cancer 94%
Similar papers in this journal
- Release of Notch activity coordinated by IL-1β signalling confers differentiation plasticity of airway progenitors via Fosl2 during alveolar regeneration 93%
- Single-cell atlas of human liver development reveals pathways directing hepatic cell fates 93%
- A biomechanical switch regulates the transition towards homeostasis in esophageal epithelium 93%
"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.